|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.85 USD | +0.72% |
|
-2.99% | +18.92% |
| 07-16 | Gilead Sciences Insider Sold Shares Worth $277,575, According to a Recent SEC Filing | MT |
| 07-16 | Gilead Sciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11:20 AM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +0.72% | -2.99% | +18.92% | +53.34% | +43.33% | 137B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition